Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Avanos Medical (NYSE: AVNS) has announced its participation in the 43rd Annual J.P.

Rhea-AI Summary

Avanos Medical (NYSE: AVNS) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Michael Greiner, the company's interim chief executive officer, will deliver a presentation on Monday, January 13, at approximately 3:45 p.m. PST.

The presentation will be accessible via webcast through the Investors section of the Avanos Medical website, where it will also be archived for future reference.

Argus Session date unavailable

+0.58% session move Open Argus

Details

News Market Reaction – AVNS

The recorded move for AVNS in the trading session of this news was +0.58%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALPHARETTA, Ga., Jan. 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will present at the 43^rd  Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Monday, Jan. 13, at approximately 3:45 p.m. PST.

A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.

About Avanos Medical, Inc. Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. For more information, visit Avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302343007.html

SOURCE Avanos Medical, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Avanos Medical (AVNS) presenting at the J.P. Morgan Healthcare Conference 2025?

Avanos Medical will present on Monday, January 13, 2025, at approximately 3:45 p.m. PST in San Francisco, California.

How can investors watch the Avanos Medical (AVNS) presentation at the JP Morgan Healthcare Conference?

Investors can watch the presentation via webcast through the Investors section of the Avanos Medical website, where it will also be archived.

Who will represent Avanos Medical (AVNS) at the 2025 J.P. Morgan Healthcare Conference?

Michael Greiner, interim chief executive officer of Avanos Medical, will present at the conference.

Which annual J.P. Morgan Healthcare Conference will Avanos Medical (AVNS) attend in 2025?

Avanos Medical will attend the 43rd Annual J.P. Morgan Healthcare Conference.